Product NDC: | 0075-0626 |
Proprietary Name: | Lovenox |
Non Proprietary Name: | enoxaparin sodium |
Active Ingredient(s): | 300 mg/3mL & nbsp; enoxaparin sodium |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0075-0626 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020164 |
Marketing Category: | NDA |
Start Marketing Date: | 19930329 |
Package NDC: | 0075-0626-03 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0075-0626-03) > 3 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0075-0626-03 |
Proprietary Name | Lovenox |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0075-0626-03) > 3 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0075-0626 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | enoxaparin sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19930329 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | ENOXAPARIN SODIUM |
Strength Number | 300 |
Strength Unit | mg/3mL |
Pharmaceutical Classes | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |